Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1967 5
1968 11
1969 19
1970 55
1971 141
1972 166
1973 193
1974 194
1975 180
1976 153
1977 179
1978 187
1979 164
1980 176
1981 158
1982 186
1983 173
1984 210
1985 204
1986 220
1987 239
1988 229
1989 294
1990 332
1991 304
1992 261
1993 280
1994 316
1995 311
1996 297
1997 316
1998 314
1999 341
2000 391
2001 392
2002 400
2003 410
2004 450
2005 474
2006 472
2007 514
2008 560
2009 555
2010 645
2011 689
2012 801
2013 834
2014 930
2015 1059
2016 1029
2017 1135
2018 1210
2019 1267
2020 1472
2021 1576
2022 1531
2023 1605
2024 718

Text availability

Article attribute

Article type

Publication date

Search Results

25,378 results

Results by year

Filters applied: . Clear all
Page 1
Antidepressant effects of ketamine in depressed patients.
Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, Krystal JH. Berman RM, et al. Biol Psychiatry. 2000 Feb 15;47(4):351-4. doi: 10.1016/s0006-3223(99)00230-9. Biol Psychiatry. 2000. PMID: 10686270 Clinical Trial.
METHODS: Seven subjects with major depression completed 2 test days that involved intravenous treatment with ketamine hydrochloride (.5 mg/kg) or saline solutions under randomized, double-blind conditions. RESULTS: Subjects with depression evidenced significant impr …
METHODS: Seven subjects with major depression completed 2 test days that involved intravenous treatment with ketamine hydrochlorid …
A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders.
Sanacora G, Frye MA, McDonald W, Mathew SJ, Turner MS, Schatzberg AF, Summergrad P, Nemeroff CB; American Psychiatric Association (APA) Council of Research Task Force on Novel Biomarkers and Treatments. Sanacora G, et al. JAMA Psychiatry. 2017 Apr 1;74(4):399-405. doi: 10.1001/jamapsychiatry.2017.0080. JAMA Psychiatry. 2017. PMID: 28249076 Review.
IMPORTANCE: Several studies now provide evidence of ketamine hydrochloride's ability to produce rapid and robust antidepressant effects in patients with mood and anxiety disorders that were previously resistant to treatment. ...OBSERVATIONS: This review and consensu …
IMPORTANCE: Several studies now provide evidence of ketamine hydrochloride's ability to produce rapid and robust antidepressan …
Ketamine applications beyond anesthesia - A literature review.
Nowacka A, Borczyk M. Nowacka A, et al. Eur J Pharmacol. 2019 Oct 5;860:172547. doi: 10.1016/j.ejphar.2019.172547. Epub 2019 Jul 23. Eur J Pharmacol. 2019. PMID: 31348905 Review.
Other reports highlight the possible use of ketamine in treating addiction, asthma and preventing cancer growth. ...This review aims to discuss the well-known and new promising applications of ketamine....
Other reports highlight the possible use of ketamine in treating addiction, asthma and preventing cancer growth. ...This review aims …
Ketamine hydrochloride (Ketalar).
[No authors listed] [No authors listed] Clin Pharmacol Ther. 1970 Sep-Oct;11(5):777-80. doi: 10.1002/cpt1970115777. Clin Pharmacol Ther. 1970. PMID: 4989499 No abstract available.
Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial.
Feder A, Parides MK, Murrough JW, Perez AM, Morgan JE, Saxena S, Kirkwood K, Aan Het Rot M, Lapidus KA, Wan LB, Iosifescu D, Charney DS. Feder A, et al. JAMA Psychiatry. 2014 Jun;71(6):681-8. doi: 10.1001/jamapsychiatry.2014.62. JAMA Psychiatry. 2014. PMID: 24740528 Clinical Trial.
Forty-one patients with chronic PTSD related to a range of trauma exposures were recruited via advertisements. INTERVENTIONS: Intravenous infusion of ketamine hydrochloride (0.5 mg/kg) and midazolam (0.045 mg/kg). MAIN OUTCOMES AND MEASURES: The primary outcome meas …
Forty-one patients with chronic PTSD related to a range of trauma exposures were recruited via advertisements. INTERVENTIONS: Intravenous in …
Zavegepant Hydrochloride.
[No authors listed] [No authors listed] Am J Health Syst Pharm. 2023 Sep 7;80(18):1199-1200. doi: 10.1093/ajhp/zxad145. Am J Health Syst Pharm. 2023. PMID: 37471249 No abstract available.
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate CA Jr, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, Charney DS, Manji HK. Zarate CA Jr, et al. Arch Gen Psychiatry. 2006 Aug;63(8):856-64. doi: 10.1001/archpsyc.63.8.856. Arch Gen Psychiatry. 2006. PMID: 16894061 Clinical Trial.
INTERVENTIONS: After a 2-week drug-free period, subjects were given an intravenous infusion of either ketamine hydrochloride (0.5 mg/kg) or placebo on 2 test days, a week apart. ...The effect size for the drug difference was very large (d = 1.46 [95% confidence inte …
INTERVENTIONS: After a 2-week drug-free period, subjects were given an intravenous infusion of either ketamine hydrochloride ( …
Global Trends and Hotspots in Esketamine Research: A Bibliometric Analysis of Past and Estimation of Future Trends.
Li X, Xiang P, Liang J, Deng Y, Du J. Li X, et al. Drug Des Devel Ther. 2022 Apr 21;16:1131-1142. doi: 10.2147/DDDT.S356284. eCollection 2022. Drug Des Devel Ther. 2022. PMID: 35478936 Free PMC article. Review.
BACKGROUND: Being the S-enantiomer of racemic ketamine, esketamine is found to be effective for sedation, analgesia, and treating depression. ...METHODS: Esketamine-related articles and reviews that published between 2000 and 2020 were obtained from the Web of Science Core …
BACKGROUND: Being the S-enantiomer of racemic ketamine, esketamine is found to be effective for sedation, analgesia, and treating dep …
Pharmacokinetics and Safety of Esketamine in Chinese Patients Undergoing Painless Gastroscopy in Comparison with Ketamine: A Randomized, Open-Label Clinical Study.
Wang J, Huang J, Yang S, Cui C, Ye L, Wang SY, Yang GP, Pei Q. Wang J, et al. Drug Des Devel Ther. 2019 Dec 6;13:4135-4144. doi: 10.2147/DDDT.S224553. eCollection 2019. Drug Des Devel Ther. 2019. PMID: 31827320 Free PMC article. Clinical Trial.
PURPOSE: To assess the pharmacokinetics and safety of pure S-ketamine (esketamine) in Chinese patients undergoing painless gastroscopy and evaluate the potential advantage of esketamine in clinical treatment compared with racemate ketamine hydrochloride injec …
PURPOSE: To assess the pharmacokinetics and safety of pure S-ketamine (esketamine) in Chinese patients undergoing painless gastroscop …
Club drugs: methylenedioxymethamphetamine, flunitrazepam, ketamine hydrochloride, and gamma-hydroxybutyrate.
Smith KM, Larive LL, Romanelli F. Smith KM, et al. Am J Health Syst Pharm. 2002 Jun 1;59(11):1067-76. doi: 10.1093/ajhp/59.11.1067. Am J Health Syst Pharm. 2002. PMID: 12063892 Review.
The abuse of methylenedioxymethamphetamine (MDMA), flunitrazepam, ketamine hydrochloride, and gamma-hydroxybutyrate (GHB) is discussed. ...The increasing abuse of MDMA, flunitrazepam, ketamine hydrochloride, and GHB, particularly by young people in soc …
The abuse of methylenedioxymethamphetamine (MDMA), flunitrazepam, ketamine hydrochloride, and gamma-hydroxybutyrate (GHB) is d …
25,378 results
You have reached the last available page of results. Please see the User Guide for more information.